Infiltrative trichilemmal carcinoma treated with 5% imiquimod cream

Dermatologic Surgery

Volumn 31, Issue 8 PART 1, 2005, Pages 973-976

  Jo, Ju Hyun ^a   Ko, Hyun Chang ^a   Jang, Ho Sun ^a   Kim, Moon Bum ^a   Oh, Chang Keun ^a   Kwon, Kyung Sool ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; NONSTEROID ANTIINFLAMMATORY AGENT; AMINOQUINOLINE DERIVATIVE; ANTINEOPLASTIC AGENT;

AGED; ANAMNESIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; CREAM; DRUG FORMULATION; ERYTHEMA; FEMALE; FEVER; HUMAN; HUMAN TISSUE; MEDICAL PRACTICE; MEDICAL SPECIALIST; PRIORITY JOURNAL; SKIN BIOPSY; SKIN CARCINOMA; SURGICAL TECHNIQUE; TRICHILEMMAL CARCINOMA; DIFFERENTIAL DIAGNOSIS; FACE; HAIR FOLLICLE; INTRADERMAL DRUG ADMINISTRATION; PATHOLOGY; REVIEW; SKIN TUMOR;

ADMINISTRATION, CUTANEOUS; AGED; AGED, 80 AND OVER; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; DIAGNOSIS, DIFFERENTIAL; FACE; FEMALE; HAIR FOLLICLE; HUMANS; SKIN NEOPLASMS;

EID: 24044494305     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1097/00042728-200508000-00016     Document Type: Article

References (14)

1. Boscaino A, Terracciano LM, Donofrio V, et al. Trichilemmal carcinoma: a study of 7 cases. J Cutan Pathol 1992;19:94-9.
2. Reis JP, Tellechea O, Cunha MF, Baptista AP. Trichilemmal carcinoma: review of 8 cases. J Cutan Pathol 1993;20:44-9.
3. Garrett AB, Azmi FH, Ogburia KS. Trichilemmal carcinoma: a rare cutaneous malignancy: a report of two cases. Dermatol Surg 2004;30:113-5.
4. Allee JE, Cotsarelis G, Solky B, Cook JL. Multiply recurrent trichilemmal carcinoma with perineural invasion and cytokeratin 17 positivity. Dermatol Surg 2003;29:886-9.
5. Headington JT. Tumors of the hair follicle. A review. Am J Pathol 1976;85:479-514.
6. Wong TY, Suster S. Tricholemmal carcinoma. A clinicopathologic study of 13 cases. Am J Dermatopathol 1994;16:463-73.
7. Hengge UR, Esser S, Schultewolter T, et al. Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol 2000;143:1026-31.
8. Ito T, Amakawa R, Kaisho T, et al. Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J Exp Med 2002;195:1507-12.
9. Miller RL, Gerster JF, Owens ML, et al. Imiquimod applied topically: a novel immune response modifier and new class of drug. Int J Immunopharmacol 1999;21:1-14.
10. Hengge UR, Stark R. Topical imiquimod to treat intraepidermal carcinoma. Arch Dermatol 2001;137:709-11.
11. Stockfleth E, Meyer T, Benninghoff B, Christophers E. Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases. Br J Dermatol 2001;144:1050-3.
12. Marks R, Gebauer K, Shumack S, et al, Australasian Multicentre Trial Group. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multi-center 6-week dose-response trial. J Am Acad Dermatol 2001;44:807-13.
13. Schroeder TL, Sengelmann RD. Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream. J Am Acad Dermatol 2002;46:545-8.
14. Kagy MK, Amonette R. The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient. Dermatol Surg 2000;26:577-9.